Dermatology
Dermatology
Advertisement
Cailin ConnerChronic Spontaneous Urticaria | June 9, 2024
According to a recent study, omalizumab treatment in patients with CSU significantly alters cytokine levels.
Read More
Cailin ConnerChronic Spontaneous Urticaria | June 8, 2024
Approximately two-thirds of patients with CSU eligible for omalizumab prescriptions were not receiving them.
Cailin ConnerChronic Spontaneous Urticaria | June 7, 2024
Successful withdrawal of omalizumab was achieved in approximately 49.5% of patients with severe CSU.
Docwire News EditorsDermatology | May 20, 2024
Henry McMillan talks the engagement of dermatologists, allergists, and APPs in training over new dermatologic treatments.
Cailin ConnerChronic Spontaneous Urticaria | May 7, 2024
A study identified the potential of 2 biomarkers for monitoring disease activity and response in children with urticaria.
Cailin ConnerChronic Spontaneous Urticaria | May 7, 2024
Nearly one-third of patients with chronic spontaneous urticaria experience non-skin-related symptoms.
Lou PorteroDermatology | April 30, 2024
less than 60% of US patients with chronic inflammatory disease (CISD) receive the requisite testing
Rebecca AraujoPublic Health | April 24, 2024
The majority of children and adolescents with chronic skin conditions reported experiencing stigma.
Cailin ConnerChronic Spontaneous Urticaria | April 23, 2024
C5a, IL-9, and apo A-IV were identified as potential biomarkers for predicting CSU severity.
Cailin ConnerChronic Spontaneous Urticaria | April 23, 2024
Autologous serum skin test positivity was associated with a delayed response to omalizumab treatment in patients with CSU.
Cailin ConnerChronic Spontaneous Urticaria | April 22, 2024
A study highlighted the underutilization of patient-reported outcome measures in the management of AD and CU.
Cailin ConnerChronic Spontaneous Urticaria | April 27, 2024
Disparities in access to omalizumab for patients with CSU significantly impact treatment patterns and health outcomes.
Cailin ConnerChronic Spontaneous Urticaria | April 22, 2024
CSU negatively affects quality of life, and patients with CSU are more likely to have worse sleep.
Lou PorteroEczema | March 25, 2024
Children whose eczema began before 4 months had more food allergies than those whose eczema began after 12 months.
Tamara ThomasEczema | March 19, 2024
Children with atopic dermatitis (eczema) may be at increased risk for developing allergic contact dermatitis.
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
Two phase 3 trials of dupilumab in chronic spontaneous urticaria demonstrated significant improvement in urticaria activity.
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
According to a meta-analysis, there are statistically significant higher mean total IgE levels in responders to omalizumab th
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
A twofold increase in dosage of desloratadine to 10 mg once daily significantly improves disease severity of CSU.
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
The SDown-CSU study emphasized a global need for clear guidance on stepping down chronic spontaneous urticaria treatment.
Cailin ConnerChronic Spontaneous Urticaria | March 14, 2024
A prospective study found that omalizumab and dupilumab effectively managed moderate-to-severe allergic diseases.
Advertisement
Advertisement
Advertisement
Latest News

June 18, 2024